Skip to main content

Table 2 Changes in visual and anatomical outcomes

From: One-year outcome of combination therapy with intravitreal aflibercept and photodynamic therapy for polypoidal choroidal vasculopathy

 

Baseline

3 months

p value

12 months

p value

Mean BCVA (LogMAR)

0.73

0.51

0.002

0.51

0.01

Mean CRT (μm)

339

249

< 0.001

244

<  0.001

Complete regression of polyps

 

16 (53.3%)

 

23 (76.7%)

 

Dry macula

 

28 (93.3%)

 

30 (100%)

 

BCVA improvement (≥ 0.3 LogMAR units)

 

8 (26.7%)

 

10 (33.3%)

 

BCVA loss (≥ 0.3 LogMAR units)

 

0 (0%)

 

2 (6.7%)

 
  1. LogMAR logarithm of the minimum angle of resolution
  2. BCVA best corrected visual acuity
  3. CRT central retinal thickness
  4. P value: comparing to baseline